Your Feed

Filter by
See content from
Back to the latest
Thumbnail for Phase 3 Asciminib Tolerability Trial , ASC4FIRST,  for Patients with CML | David Andorsky |#ASH2024
Playlist: ASH 2024

Phase 3 Asciminib Tolerability Trial , ASC4FIRST, for Patients with CML | David Andorsky |#ASH2024

Video details & playlist
Thumbnail for The Phase 2 ASC2ESCALATE Trial Evaluating Asciminib for CML Patients | David Andorsky, MD | #ASH2024
Playlist: ASH 2024

The Phase 2 ASC2ESCALATE Trial Evaluating Asciminib for CML Patients | David Andorsky, MD | #ASH2024

Video details & playlist
Thumbnail for Race, Ethnicity, and Socioeconomics Tied to Disparities in Myelofibrosis | Anand Patel, MD | #ASH24
Playlist: ASH 2024

Race, Ethnicity, and Socioeconomics Tied to Disparities in Myelofibrosis | Anand Patel, MD | #ASH24

Video details & playlist
Thumbnail for Fedratinib Helps Myelofibrosis Patients with Low Platelet Counts | Haifa Katrhin Al-Ali, MD | #ASH24
Playlist: ASH 2024

Fedratinib Helps Myelofibrosis Patients with Low Platelet Counts | Haifa Katrhin Al-Ali, MD | #ASH24

Video details & playlist
Thumbnail for Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70? | Muhammad Umair Mushtaq | #ASH24
Playlist: ASH 2024

Are Stem Cell Transplants Safe for Myelofibrosis Patients Over 70? | Muhammad Umair Mushtaq | #ASH24

Video details & playlist